Didem Saygin to Treatment Outcome
This is a "connection" page, showing publications Didem Saygin has written about Treatment Outcome.
Connection Strength
0.141
-
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3672-3679.
Score: 0.117
-
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide. Rheumatology (Oxford). 2020 Sep 01; 59(9):2264-2271.
Score: 0.024